MedPath

The PsoTeenQOL - Preliminary Reliability and Validity

Completed
Conditions
Psoriasis
Interventions
Other: No intervention
Registration Number
NCT03358914
Lead Sponsor
University of Aarhus
Brief Summary

This study aims to develop and provide preliminary reliability and validity of a questionnaire to measure Health-related Quality of Life (HRQOL) in adolescents with psoriasis. To the best of our knowledge, this will be the first psoriasis-specific HRQOL instrument for use in adolescent patients. Data will be collected from a Danish population of adolescents with psoriasis (12-17 years), as well as from parents of adolescents with psoriasis, and a group of adolescents without psoriasis.

Detailed Description

The present study will examine the psychometric properties of a preliminary 41-item version of the PsoTeenQOL. The preliminary PsoTeenQOL has been developed based on qualitative interviews of adolescents (12-17 years) with psoriasis, their parents, and health professionals working within the field, as well as literature reviews and existing questionnaires. Face and content validity has been established through subsequent cognitive interviews with the target group.

Exploratory factor analysis (EFA) and analysis of differential item functioning (DIF) will be used to further refine the PsoTeenQOL questionnaire by selecting the most appropriate items. In addition, indicators of reliability (internal consistency; test-retest reliability), validity (construct validity, criterion validity; discriminant validity), and responsiveness will be evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
233
Inclusion Criteria
  • Either a) Subjects with psoriasis, b) Parents of adolescents 12-17 years with psoriasis, or c) Subjects without psoriasis
  • Ability to read Danish and complete electronic survey
Read More
Exclusion Criteria
  • Inability to read Danish and complete electronic survey
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adolescents without psoriasisNo interventionNo assigned intervention: completion of non-psoriasis control-version of the PsoTeenQOL for validation purposes
Adolescents with psoriasisNo interventionNo assigned intervention: completion of PsoTeenQOL and other instruments for assessment of psychometric properties and further refinement of the PsoTeenQOL.
Parents of adolescents with psoriasisNo interventionNo assigned intervention: completion of proxy-version of the PsoTeenQOL for validation purposes
Primary Outcome Measures
NameTimeMethod
Examine the psychometric properties of the PsoTeenQOLBaseline and up to 3 months after first completion of questionnaire package

Analyses will include exploratory factor analysis, examination of differential item functioning (DIF) and evaluation of indicators of reliability and validity of the instrument

Secondary Outcome Measures
NameTimeMethod
Indicators of reliabilityTest-retest: 2 weeks (+/-3 days) after baseline; Responsiveness: 3 months after baseline

Internal consistencies (Cronbach's alpha), test-retest reliability and responsiveness of the PsoTeenQOL (change scores on the PsoTeenQOL as compared to the CDLQI and disease severity indicators)

Indicators of validityBaseline

Correlations and comparisons between PsoTeenQOL and similar non-psoriasis-specific instruments (Children's Dermatology Life Quality Index (CDLQI); Pediatric Quality of Life Inventory (PedsQL); WHO-5, proxy- and non-psoriasis control version of the PsoTeenQOL) as well as measures of disease severity (Self-assessed Simplified Psoriasis Index (saSPI), and Psoriasis Area Severity Index (PASI)).

Trial Locations

Locations (1)

Aarhus University

🇩🇰

Aarhus C, Denmark

© Copyright 2025. All Rights Reserved by MedPath